[{"address1": "680 East Colorado Boulevard", "address2": "Suite 180", "city": "Pasadena", "state": "CA", "zip": "91101", "country": "United States", "phone": "631 830 7092", "fax": "631 982 5050", "website": "https://lixte.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bastiaan  van der Baan M.Sc.", "age": 52, "title": "President, Chief Scientific Officer & Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 172784, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Neal Weingarten", "age": 72, "title": "CFO, VP & Secretary", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 175000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Geordan G. Pursglove", "age": 36, "title": "CEO & Chairman", "yearBorn": 1988, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Johannes Henricus Matthias Schellens M.D., Ph.D.", "age": 67, "title": "Consultant & Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.29, "open": 4.2, "dayLow": 3.9, "dayHigh": 4.35, "regularMarketPreviousClose": 4.29, "regularMarketOpen": 4.2, "regularMarketDayLow": 3.9, "regularMarketDayHigh": 4.35, "payoutRatio": 0.0, "beta": 0.31, "volume": 147242, "regularMarketVolume": 147242, "averageVolume": 2071888, "averageVolume10days": 348380, "averageDailyVolume10Day": 348380, "bid": 3.77, "ask": 4.43, "bidSize": 3, "askSize": 3, "marketCap": 12441751, "fiftyTwoWeekLow": 0.64, "fiftyTwoWeekHigh": 4.48, "fiftyDayAverage": 1.9756, "twoHundredDayAverage": 1.78235, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 13146847, "profitMargins": 0.0, "floatShares": 2603605, "sharesOutstanding": 3027190, "sharesShort": 122174, "sharesShortPriorMonth": 4456, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0404, "heldPercentInsiders": 0.18032, "heldPercentInstitutions": 0.15499, "shortRatio": 0.02, "shortPercentOfFloat": 0.040900003, "impliedSharesOutstanding": 3027190, "bookValue": -0.872, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -3324198, "trailingEps": -1.45, "lastSplitFactor": "1:10", "lastSplitDate": 1685923200, "52WeekChange": 0.8767123, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 4.11, "recommendationKey": "none", "totalCash": 1384697, "totalCashPerShare": 0.516, "totalDebt": 0, "quickRatio": 3.899, "currentRatio": 4.264, "returnOnAssets": -0.81143, "returnOnEquity": -1.5513699, "freeCashflow": -1725609, "operatingCashflow": -2943794, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "LIXT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2071888, "fiftyTwoWeekLowChange": 3.4700003, "fiftyTwoWeekLowChangePercent": 5.4218755, "fiftyTwoWeekRange": "0.64 - 4.48", "fiftyTwoWeekHighChange": -0.3699999, "fiftyTwoWeekHighChangePercent": -0.08258926, "fiftyTwoWeekChangePercent": 87.671234, "dividendDate": 1605830400, "earningsTimestamp": 1747053000, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.45, "fiftyDayAverageChange": 2.1344001, "fiftyDayAverageChangePercent": 1.0803807, "twoHundredDayAverageChange": 2.32765, "twoHundredDayAverageChangePercent": 1.3059444, "priceToBook": -4.713303, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "longName": "Lixte Biotechnology Holdings, Inc.", "corporateActions": [], "postMarketTime": 1753484384, "regularMarketTime": 1753473601, "exchange": "NCM", "messageBoardId": "finmb_29181356", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.1958, "regularMarketPrice": 4.11, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1193319000000, "postMarketChangePercent": 1.45985, "postMarketPrice": 4.17, "postMarketChange": 0.0599999, "regularMarketChange": -0.18, "regularMarketDayRange": "3.9 - 4.35", "shortName": "Lixte Biotechnology Holdings, I", "marketState": "CLOSED", "displayName": "Lixte Biotechnology", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]